To Access the Effects of Mucositis in Adults With Dental Implants (implantitis)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01072201|
Recruitment Status : Completed
First Posted : February 19, 2010
Results First Posted : February 19, 2010
Last Update Posted : October 5, 2010
|Condition or disease||Intervention/treatment||Phase|
|Mucositis||Drug: Triclosan and Fluoride Drug: Fluoride||Phase 3|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||60 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||To Access the Effects of Mucositis in Adults With Dental Implants|
|Study Start Date :||June 2007|
|Actual Primary Completion Date :||December 2007|
|Actual Study Completion Date :||December 2007|
Experimental: Total toothpaste
Drug: Triclosan and Fluoride
Brush twice daily
Other Name: Total Toothpaste
Placebo Comparator: Ultrabrite toothpaste
Brush twice daily
Other Name: Ultrabrite toothpaste
- Bleeding on Probing [ Time Frame: 6 months ]Percentage of Bleeding Scale: The bleeding sites are identified by either a 0 or 1. (0=no bleeding & 1= bleeding) The number of spots between teeth that bleed are divided by number of spots between teeth that are scored.
- Mean Pocket Depth [ Time Frame: 6 Months ]Measurement scale: 0 millimeter measurement= no pocket depth. 3, 4, 5, & 6 millimeter are indications of deeper Pocket depth.
- Mean Percentage of Plaque Scores [ Time Frame: 6 Months ]Mean Percentage (%) of dental plaque on all tooth surfaces, including implants and natural teeth. Plaque Scale is 0=no plaque and 1= dental plaque present. Percentage is derived from sum of all plaque scores divided by the number of tooth surfaces scored.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01072201
|Ariminum Research & Dental Education Center|
|Principal Investigator:||Per Ramberg, DDS|